Streetbeat News

Stock Prices

TCNNF

The Florida legislature and Governor Ron DeSantis estimate that legalizing cannabis could generate between $195.6 million and $431.3 million in annual sales tax revenue. A legalization initiative is expected to go to the voters in 2024. The legalization movement received significant financial support from Florida-based Trulieve Cannabis Corp. (OTCQX: TCNNF), which has contributed at least $39 million to the Smart & Safe Florida campaign.

Portfolio Pulse from Maureen Meehan

July 17, 2023 | 7:09 pm

BBIO

GNTY

GP

JZXN

NOVN

PMN

VRAY

U.S. stocks traded higher with the Dow Jones gaining 0.25%. Guaranty Bancshares (GNTY) reported better-than-expected Q2 results. ProMIS Neurosciences (PMN), BridgeBio Pharma (BBIO), and GreenPower Motor Company (GP) saw their shares rise after positive news. Novan (NOVN), ViewRay (VRAY), and Jiuzi Holdings (JZXN) shares fell due to various reasons. Oil traded down 1.8% to $74.08.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 7:05 pm

JNJ

A significant investor has taken a bearish stance on Johnson & Johnson (NYSE:JNJ), with 90% of recent trades being bearish. The trades range from $105.0 to $175.0. The price of JNJ is currently down -0.39% at $159.24. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $215, while Morgan Stanley maintains an Equal-Weight rating with a price target of $187.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

PFE

A significant investor has taken a bearish stance on Pfizer (NYSE:PFE), with 53% of recent trades being bearish and 46% bullish. The total amount for put options was $1,310,868 and for call options $253,745. Whales have been targeting a price range from $25.0 to $40.0 for Pfizer over the last 3 months. Pfizer's current price is $36.04, down 0.77%. Several financial institutions have downgraded their actions on Pfizer, with price targets ranging from $40 to $75.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

PTLO

Over the past 3 months, 4 analysts have published their opinion on Portillos (NASDAQ:PTLO) stock, with an average price target of $25.5 versus the current price of $22.85. The average price target has increased by 4.81% over the past month. The analysts are generally bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

OKE

ONEOK (NYSE:OKE) has outperformed the market over the past 20 years, producing an average annual return of 9.43%. If an investor had bought $1000 of OKE stock 20 years ago, it would be worth $6,087.00 today. ONEOK currently has a market capitalization of $28.49 billion.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:01 pm

MKRUSD

Cryptocurrency Maker (MKR) has seen a price drop of 5.05% in the last 24 hours, continuing its negative trend over the past week. The trading volume of MKR has increased by 67.0% over the past week, moving in tandem with the overall circulating supply of the coin, which has increased 0.03%. The current market cap ranking for MKR is #50 at $839.27 million.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

BG

Four analysts have provided ratings for Bunge (NYSE:BG) in the last quarter, with one bullish, two somewhat bullish, and one indifferent. The average price target is $121.0, compared to Bunge's current price of $101.44, implying an upside. The average price target has increased by 5.22% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

WRB

WR Berkley (NYSE:WRB) has received 4 analyst ratings in the last quarter, with 1 being bullish and 3 somewhat bullish. The company has an average 12-month price target of $78.25, representing a 1.57% decrease from the previous average price target of $79.50.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm

AAVEUSD

Cryptocurrency Aave (CRYPTO: AAVE) has seen a decrease of 5.15% in its price over the past 24 hours to $74.19, despite an overall uptrend of 4.0% over the past week. The trading volume of Aave has increased by 3.0% over the past week, and the circulating supply has increased by 0.26% to 14.49 million, which is approximately 90.53% of its max supply of 16.00 million. Aave's current market cap ranking is #41 at $1.07 billion.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 7:00 pm